July 01, 2014
Ultragenyx Announces Initiation of a Phase 2 Study of KRN23 for Pediatric X-Linked Hypophosphatemia in the US and EU
Media
June 30, 2014
Orexo Added to Russell Global Index
May 24, 2014
HealthCap Presentation Farmasidagene 2014 Oslo
May 14, 2014
Nordic Nanovector Q1 2014 results
May 05, 2014
Q1 2014 General Market Overview
April 25, 2014
Orexo reports Q1 2014 results
March 24, 2014
The Importance of Venture Capital (Swedish)
March 03, 2014
The Investor’s Perspective on Life Science Investments.
February 07, 2014
Q4 2013 General Market Overview
December 23, 2013
Five Prime Therapeutics Announces Closing of IPO